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AntimicrobialAbstract The extracts obtained from Anacardium occidentale leaf were investigated for antioxidant
and antimicrobial activities. Bioassay-guided fractionation using DPPH autobiographic analysis of
the EtOAc soluble fraction of the crude extract resulted in the isolation of agathisﬂavone (1) and a
mixture of quercetin 3-O-rutinoside (2) and quercetin 3-O-rhamnoside (3). Characterization of the
isolated compounds was carried out using nuclear magnetic resonance (1D and 2D) and mass spec-
trometry. The antioxidant activities of the samples were determined using three complementary
tests, namely; DPPH-radical scavenging, total antioxidant capacity (TAC) and ferric reducing
antioxidant power (FRAP). The antimicrobial activity of the samples was evaluated using the disc
diffusion and broth microdilution methods. The results indicated that the mixture (ratio 2:1) of
compounds (2) and (3) was most active in its capacity to scavenge free radicals in the DPPH assay
[IC50 = 0.96 ± 0.01 lg/mL] compared to the ethyl acetate (EtOAc) fraction, the ascorbic acid and
quercetin standards. The mixture of compounds (2) and (3) exhibited the highest activities in the
TAC assay (5332.00 ± 3.38 mg AAE/g, 8562.00 ± 5.43 mg QE/g) and FRAP assay (15,136.00 ±
7.14 mg AAE/g, 199,530.00 ± 94.12 mg QE/g) compared to the EtOAc fraction. The fractions of
the extract showed comparatively better activities against gram-negative than the gram positive
ones with the broadest spectrum of activities demonstrated for the ethyl acetate fraction. No inhi-
bitions were obtained against the fungal strains investigated. The isolated compounds from the
plant possess essentially inhibitory rather than cidal activities against these organisms with the
Minimum Bactericidal Concentrations (MBCs) >2.0 mg/mL in all cases. The mixture of
Compound isolation and characterization from Anacardium occidentale L. 245compounds 2 and 3 showed higher activity than compound 1 with the former having MIC as low as
0.25 mg/mL against Pseudomonas aeruginosa and Clostridium sporogens, 0.5 mg/mL against
Staphylococcus aureus and 1.0 mg/mL against Escherichia coli and Klebsiella pneumonia strains
investigated while the latter has an MIC of 1.0 mg/mL against most of the organisms.
This study concluded that the extracts and isolated compounds had strong antioxidant and
moderate antibacterial activities and could be effective in the management of oxidative stress related
diseases. These ﬁndings also justiﬁed the use of this plant’s extracts in folk medicine.
ª 2014 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Anacardium occidentale L. is a tree in the family of the ﬂower-
ing plant Anacardiaceae. Extracts from roots, stems and fruits
are extensively used in folk medicine for infectious, inﬂamma-
tory and oxidative stress conditions (Sokeng et al., 2001; Chen
and Chung 2000; Ojewole, 2004; Olajide et al., 2004, 2013).
The leaf and/or the stem bark are used for eczema, genital
problems, venereal diseases, impotence, bronchitis, cough
and syphilis-related skin disorders (Franca et al., 1993). Tradi-
tional medicine in West Africa and South America uses the leaf
infusion in the treatment of gastrointestinal disorders (acute
gastritis, diarrhoea), mouth ulcers and throat problems
(Kudi et al., 1999; Akinpelu, 2001; Goncalves et al., 2005;
Taylor, 2005).
Analysis of the ethyl acetate fraction of a 70% ethanol leaf
extract of A. occidentale using liquid chromatography coupled
to mass spectrometry (LC/ESI-MS) indicated the presence of
phenolic compounds such as: quercetin, myricetin, catechin,
epicatechin, amentoﬂavone, tetramer of proanthocyanidin
and unidentiﬁed quercetin glycosides (Konan and Bacchi,
2007). Flavonoids such as: quercetin, quercetin 3-O-rhamno-
side, myricetin, and myricetin-3-O-rhamnoside were reported
from the leaf extracts (Arya et al., 1989). Fractionation of
the ethyl acetate fraction of the crude ethanol seed extract
on Sephadex LH-20 column chromatograph resulted in the
isolation of a mixture of catechin and epicatechin, while frac-
tionation of the hexane fraction of the crude ethanol extract of
the stem bark afforded sitosterol and estimasterol (Chaves
et al., 2010).
Many of the phytochemical studies (De Brito et al., 2007;
Paramashivappa et al., 2001; Shobba and Ravindranath,
1991) on the extracts of A. occidentale did not link speciﬁc
activity to the identiﬁed constituents. In our continuing efforts
for potent antioxidant and antimicrobial agents from natural
sources, we have investigated the leaf extracts of A. occidentale
for its bioactive constituents.2. Materials and methods
2.1. General
All analyses of samples (fractions and isolated compounds)
using thin layer chromatography (TLC) were performed at
room temperature using pre-coated plates (MERCK, silica
gel 60 F254 0.2 mm). Detection of spots was by ultraviolet lamp
(254 and 366 nm). Silica gel and Sephadex LH-20 were used as
stationary phases for column chromatography to fractionate
active fractions. Nuclear magnetic resonance (NMR) spectradata were obtained from a Brucker Spectrometer. Chemical
shifts are expressed in parts per million (ppm). Mass spectrum
(TOF MS ES) was obtained from a Thermoﬁnnigan Trace GC
coupled to a Polaris Q Mass Spectrometer.
2.2. Plant material
The leaves of A. occidentale were collected (November 2010) at
Obafemi Awolowo University Ile-Ife, Nigeria. Mr. Ibenesibor
of the Herbarium Section, Department of Botany, OAU, Ile-
Ife, authenticated the plant material collected. The voucher
specimen (IFE Herbarium: 16834) was deposited at the
University Herbarium. The collected leaves were air dried at
room temperature for two weeks and ground to powder.
2.2.1. Extraction procedure
Powdered material (1.8 kg) was extracted with 80% methanol
(10 L) with occasional shaking for 24 h. The extract was ﬁl-
tered and the ﬁltrate was concentrated to about of its original
volume using a rotary evaporator at 40 C. This afforded the
crude extract of the plant (700 mL).
2.2.2. Solvent partitioning of the crude extracts
The crude extract obtained was suspended in distilled water in
a separating funnel (5 L) and in turn partitioned with n-hexane
(HEX), dichloromethane (DCM), ethyl acetate (EtOAc) and n-
butanol (BuOH). This yielded four solvent fractions.
2.3. Qualitative screening for the antioxidant compounds
About 10 lL of each of the four fractions (1 mg/mL) obtained
were spotted on silica gel TLC plate, the chromatogram was
developed in DCM/MeOH (8.5:1.5) and the plates were
sprayed with 0.2% 1,1-diphenyl-2-picrylhydrazyl (DPPH) in
MeOH for detection of antioxidant compounds in each of the
fractions. From the chromatogram (results not shown), it was
found that ethyl acetate and butanol fractions contained more
antioxidant compounds than n-hexane and dichloromethane
fractions. Ethyl acetate fraction which showed the highest num-
ber of antioxidant spots was selected for fractionation.
2.4. Isolation of antioxidant compounds from ethyl acetate
fraction of A. occidentale
Accelerated Column Chromatography (AGC) using silica gel
(230–400 mesh) as the stationary phase was used to fractionate
ethyl acetate fraction (27.0 g). The column was eluted with
n-hexane 100% followed by an increasing gradient of ethyl
acetate starting with 10% up to 100% ethyl acetate. This
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10% in ethyl acetate up to 100% methanol. Test tube fractions
(15 mL each) collected were analysed on TLC plates using
Hexane/EtOAc (3:7). This afforded ﬁve fractions (A1–E1).
From the chromatogram, fractions B1 and C1 had antioxi-
dant compounds. Fractionation of B1 (9.8 g) on a silica gel col-
umn using hexane (100%) was followed by an increased
gradient of ethyl acetate up to 100%. This was followed in turn
by an increasing gradient of methanol up to 20%. Test tube
fractions collected were analysed on TLC plate using Hex-
ane/EtOAC (1:4) solvent system. Three fractions, A2–C2 were
obtained. Open column chromatography using Sephadex LH-
20 as stationary phase was used to fractionate B2 (5.8 g). The
column was eluted using Hexane/EtOAc (1:1) followed by an
increasing gradient of EtAOc up to 100%. Analysis of the frac-
tions collected on TLC plate using 100% EtOAc yielded three
fractions A3–C3. B3 was further puriﬁed on silica gel column
using hexane (100%) followed by an increasing gradient of
ethyl acetate up to 100%. This was followed in turn by an
increasing gradient of methanol up to 10%. Analysis of the test
tubes fractions collected on silica gel TLC plate using EtOAc:-
MeOH (9:1) showed that tubes 3–18 had single spots, this
afforded compound 1 (19 mg).
Puriﬁcation of C2 (1.9 g) was achieved by its fractionation
on silica gel column eluted with dichloromethane followed
by an increasing gradient of methanol up to 25%. The frac-
tions collected in the test tubes were analysed on TLC plate
using DCM/MeOH (4:1). Test tube 14–17 showed single spots,
this yielded a mixture of compounds 2 and 3.2.4.1. Structure elucidation of isolated compounds
Isolated compounds were characterized using spectroscopic
techniques: mass spectrometry (ESI-TOF-MS), 1H (400 MHz)
and 13C NMR (100 MHz), and DEPT together with 2D exper-
iments (gCOSY, gHSQC and gHMBC).
2.4.1.1. Compound 1. Compound 1 (19 mg) was obtained as
yellow powder. Its mass spectrum (TOF-MS-ES) showed
the pseudo-molecular ion peak as the base peak at m/z=
537.0826, [MH], consistent with the molecular formula
C30H18O10. The
1H NMR (MeOD) of 1 showed signals
between d 7.91 and 6.38 mainly aromatic protons. The spec-
trum showed two separate doublets (ortho coupled related
protons) at d 7.90 (2H, d, J= 8.0 Hz, H-20, H-60) and 6.96
(2H, d, J= 8.0 Hz, H-30, H-50) for 1, 4-disubstituted phenyl
ring (ring B) representing an A2B2 ring system, along with
two separate singlet signals at 6.58 (1H, s, H-30 0) and 6.66
(1H, s, H-3). Another ortho coupled two separate doublets
appeared at d 7.54 (2H, d, J= 8.0 Hz, H-20 00, H-60 00) and
6.75 (2H, d, J= 8.0 Hz, H-30 0 0, H-50 0 0) for the second ring B.
Two separate singlets also appeared at 6.70 (1H, s, H-8) and
6.38 (1H, s, H-60 0). The 13C NMR and DEPT spectra of this
compound revealed the presence of 26 carbons. Eight of these
carbons were classiﬁed as protonated from DEPT spectrum,
out of which four were assigned to two units of 1,4-disubsti-
tuted phenyl and another two were characteristic of a ﬂavone
(C-3) signal. The remaining two protonated carbons were
assigned to C-8 and C-60 0. The positions of attachment of the
two ﬂavone units were established by 2D NMR, Compound
1 was determined to be agathisﬂavone (Fig. 1). The 13C
NMR (MeOD) – 166.4 (C-2), 104.1 (C-3), 184.4 (C-4), 161.5(C-5), 104.9 (C-6), 164.5 (C-7), 94.8 (C-8), 159.2 (C-9), 105.4
(C-10), 123.4 (C-10), 129.6 (C-20), 117.0 (C-30), 162.9 (C-40),
117.0 (C-50), 129.6 (C-60), 166.2 (C-200), 103.6 (C-300), 184.1
(C-400), 162.6 (C-50 0), 100.0 (C-60 0), 164.2 (C-700), 100.4 (C-80 0),
157.1 (C-900), 105.7 (C-100 0), 123.5 (C-100 0), 129.4 (C-200 0),
117.2 (C-30 00), 162.7 (C-400 0), 117.2 (C-500 0), 129.4 (C-600 0). The
spectroscopic data are in agreement with the literature
(Svenningsen et al., 2006).
2.4.1.2. Mixture of compounds 2 and 3. The mixture of com-
pounds 2 and 3 (80 mg) was obtained as brown powder. The
mixture components were identiﬁed by NMR spectra (mainly
2D) peak intensities. The higher intensity signals were allo-
cated to compound 2 while the lower intensity signals were
assigned to compound 3. The ratio of the two components in
the mixture was also determined by comparison of the signal
intensities as 2:1 for compounds 2 and 3 in the mixture. The
1H NMR of 2 in the mixture showed aromatic signals indicat-
ing the presence of 1,3,4-trisubstituted ring B representing an
ABX ring system. The spectrum peaks appeared at d 7.62
(1H, d, J= 2.1 Hz, H-20), 7.59 (1H, dd, J= 2.2 and 8.4 Hz,
H-60) and 6.87 (1H, d, J= 8.4 Hz, H-50). Two separate meta
coupled doublets appeared at d 6.38 (1H, d, J= 2.1 Hz, H-
8) and 6.20 (1H, d, J= 2.1 Hz, H-6) for ring A. The 1H
NMR (MeOD) of 3 represented by lower intensity signals
showed a meta related doublet at d 7.34 (1H, d, J= 2.1 Hz,
H-20), ortho and meta related doublet of doublet at d 7.31
(1H, dd, J= 2.1 and 8.3 Hz, H-60) and ortho related doublet
at d 6.92 (1H, d, J= 8.3 Hz, H-50) for ring B indicating second
ABX ring unit. Another two separate meta related doublets
also appeared at d 6.36 (1H, d, J= 2.1 Hz, H-8) and 6.20
(1H, d, J= 2.1 Hz, H-6) for the ring A of the second ﬂavonoid
ring. The 13C NMR and DEPT spectra of these compounds
revealed the presence of two quercetin derivatives. There was
the presence of sugar signals indicating rhamnosyl and gluco-
syl moieties. Anomeric proton of rhamnosyl appeared at d 5.36
(1H, d, J= 1.56 Hz) while that of glucosyl appeared at d 5.17
(1H, d, J= 7.2 Hz). In the 13C NMR (100 MHz, MeOD) spec-
trum, there were thirty carbon signals for the two ﬂavonoid
units in addition to the sugar signals. The anomeric carbon
of the rhamnosyl appeared at d 103.4 and C-6 at d 17.7. Glu-
cosyl anomeric carbon appeared at d 104.4 and C-6 at d 67.3.
The 2D NMR (HMBC) of this compound mixture revealed
that the anomeric of the rhamnosyl attached to the C-6 of
the glucosyl making the sugar a disaccharide (rutinosyl). How-
ever, the HMBC spectrum further showed that there are two
points of attachment for rhamnosyl indicating the presence
of two units of rhamnosyl in the mixture. This is indicated
by the intensities of the rhamnosyl signals in the 13C NMR.
The point of attachment of the rutinosyl correlated to C-3 of
aglycone of compound 2 at d 135.5 while the second point of
attachment of the second unit of rhamnosyl appeared at C-3
of compound 3 at d 136.3.
Compound 2: 13C NMR (MeOD): 159.0 (C-2), 135.5 (C-3),
179.5 (C-4), 163.1 (C-5), 100.0 (C-6), 166.1 (C-7), 94.8 (C-8),
158.5 (C-9), 105.7 (C-10), 123.4 (C-10), 117.3 (C-20), 146.1 (C-
30), 150.0 (C-40), 116.1 (C-50), 123.0 (C-60), 104.4(C-100), 73.4
(C-200), 77.6 (C-30 0), 72.1 (C-40 0), 75.3 (C-500), 67.3 (C-60 0),
103.4 (C-10 0 0), 72.0 (C-200 0), 72.1 (C-30 0 0), 72.3 (C-40 00), 71.1
(C-500 0), 17.7 (C-600 0).
Compound 3: 13C NMR (MeOD): 159.4 (C-2), 135.3 (C-3),
179.7 (C-4), 163.2 (C-5), 99.9 (C-6), 165.9 (C-7), 94.8 (C-8),
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Figure 1 Antioxidant constituents of A. occidentale leaf extract.
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(C-30), 149.8 (C-40), 116.5 (C-50), 123.1 (C-60), 103.4 (C-100),
72.0 (C-200), 72.1 (C-30 0), 72.3 (C-40 0), 71.1 (C-50 0), 17.7 (C-600).
The spectra data are in good agreement with the literature
(Aderogba et al., 2006 and Aderogba et al., 2012) for com-
pounds 2 and 3 respectively.
2.5. Antioxidant assays
2.5.1. DPPH-radical scavenging assay
DPPH radical scavenging activities of the test samples were
measured according to the method of Brand-Williams et al.
(1997). An aliquot of 1 mL of 0.004% DPPH solution in eth-
anol and 1 mL of test samples at various concentrations by
serial dilution (starting with 100 lg/mL for crude, hexane
and dichloromethane extracts, 10 lg/mL for ethyl acetateand butanol extracts, 200 lg/mL for compound 1 and 10 lg/
mL for mixture of compounds 2 and 3) were mixed and incu-
bated at 37 C for 30 min. The absorbance of test samples was
read at 517 nm. The percentage inhibition of DPPH radical by
the test samples was calculated by comparing the results
obtained with those of the control using the formula:
%Inhibition ¼ f½ABSControl ABSTest=ABSControlg  100
ABSControl is the absorbance of the negative control; ABSTest is
the absorbance of test samples.
2.5.2. Determination of total antioxidant capacity
The total antioxidant capacity (TAC) of the test sample was
performed by the phosphomolybdenum method of Prieto
et al. (1999) with slight modiﬁcations. Brieﬂy 1 mL of the
reagent solution consisting of 28 mM sodium phosphate
Table 1 DPPH radical scavenging activity of fractions and
isolated compounds from A. occidentale.
Sample Mean IC50 (lg/mL)
Ascorbic acid 4.57 ± 0.07
Quercetin 3.01 ± 0.14
Crude 9.94 ± 0.14
Hexane 157.49 ± 1.00
Dichloromethane 85.13 ± 1.50
Ethyl acetate 5.66 ± 0.16
Butanol 7.77 ± 0.34
1 366.37 ± 32.59
2 and 3 0.96 ± 0.01
Data represents mean ± S.E.M. of triplicate determinations.
DPPH free radical scavenging activity is expressed as IC50 (lg/mL)
values.
Table 2 Total antioxidant capacity of fractions and isolated
compounds from A. occidentale.
Sample mg AAE/g mg QE/g
Crude 1997.00 ± 5.63 3206.15 ± 9.04
Hexane 1611.00 ± 7.90 2587.71 ± 12.66
Dichloromethane 1865.00 ± 15.77 2994.58 ± 25.32
Ethyl acetate 2080.00 ± 5.64 3339.97 ± 9.05
Butanol 2087.00 ± 7.89 3350.82 ± 12.66
1 2782.00 ± 15.77 4467.00 ± 25.32
2 and 3 5332.00 ± 3.38 8562.00 ± 5.43
Data represents mean ± S.E.M. of triplicate determinations. Total
antioxidant capacity is expressed as mg Ascorbic acid equivalent
per g (mg AAE/g) and mg quercetin equivalent per g (mg QE/g) of
the test samples.
Table 3 Ferric reducing antioxidant power (FRAP) of frac-
tions and isolated compounds from A. occidentale.
Sample mg AAE/g mg QE/g
Crude 3038.00 ± 3.57 40,047.00 ± 47.06
Hexane 1639.00 ± 28.56 21,600.00 ± 376.47
Dichloromethane 2813.00 ± 103.53 37,082.00 ± 1364.7
Ethyl acetate 3051.00 ± 1.65 40,212.00 ± 23.53
Butanol 3056.00 ± 3.57 40,282.00 ± 47.06
1 1714.00 ± 28.56 22,590.00 ± 376.47
2 and 3 15,136.00 ± 7.14 199,530.00 ± 94.12
Data represents mean ± S.E.M. of triplicate determinations.
FRAP Antioxidant activity is expressed in Ascorbic acid equivalent
mg per g (mg AAE/g) and quercetin equivalent mg per g (mg QE/g)
of samples.
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phuric acid was mixed with 100 lL of the test sample (1 mg/
mL for crude and fractions, and 200 lg/mL for compounds).
The reaction mixture was then incubated at 95 C for
90 min. The reaction mixture was then cooled under running
water and the absorbance measured at 695 nm. Total antioxi-
dant capacity was calculated as mg ascorbic acid equivalent/g
(mg AAE/g) and mg quercetin equivalent/g (mg QE/g) of test
sample.
2.5.3. Determination of ferric reducing antioxidant power
(FRAP)
The ferric reducing antioxidant power (FRAP) assay was car-
ried out as previously described by Benzie and Strain (1999). A
300 mmol/L of acetate buffer (pH 3.6), 10 mmol/L of 2,4,6-tris
(2-pyridyl)-1,3,5-triazine, and 20 mmol of ferric chloride were
mixed together in the ratio 10:1:1 respectively to give the
FRAP working reagent. To 50 lL solution of the different test
samples (1 mg/mL for crude and solvent fractions, and 200 lg/
mL for compounds) 1 mL of the working FRAP reagent was
added. The reaction mixtures were then incubated at 37 C
for 10 min and the absorbance then read at 593 nm in a spec-
trophotometer. The test was carried out in triplicate and ascor-
bic acid and quercetin were used as reference standards. The
ferric reducing antioxidant power was calculated as equiva-
lence of ascorbic acid and quercetin (mg AAE/g) and
(mg QE/g).
2.6. Antimicrobial assay
2.6.1. Test organisms
The strains used were Escherichia coli, American Type Culture
Collection (ATCC) 25922, Pseudomonas aeruginosa, American
Type Culture Collection (ATCC) 27853, Staphylococcus aur-
eus, American Type Culture Collection (ATCC) 29213, Pro-
teus mirabilis (clinical strain), Bacillus subtilis, National
Culture of Industrial Bacteria (NCIB) 3610, Klebsiella pneumo-
nia (clinical strain) and Clostridium sporogens, National Cul-
ture of Industrial Bacteria (NCIB) 532 for bacteria and
Candida albicans National Collection of Yeast Culture
(NCYC) 6 and Candida pseudotropicalis (clinical strain) for
fungi. The strains were from stocks of culture collections main-
tained in the Pharmaceutical Microbiology laboratory of theDepartment of Pharmaceutics, Faculty of Pharmacy, Obafemi
Awolowo University where the experiments were performed.
2.6.2. Agar diffusion test
Bacteria were maintained both in cryopreservation medium
and on nutrient agar slants while fungi were maintained on
Sabouraud Dextrose Agar slants at 4 C and subcultured
monthly. The crude extract and the fractions were each
dissolved in MeOH/H2O or DMSO as appropriate to give
varying concentrations ranging from 0.5 to 20 mg/mL,
(Table 4). The agar diffusion test followed the procedure
described in Aiyelabola et al. (2012) and antimicrobial activity
was evaluated by noting the zone of inhibition against the test
organisms.
2.6.3. The antimicrobial screening of pure compounds
The MIC values of the isolated compounds against the bacteria
strains were determined using the micro-well dilution method
as described by Zgoda and Porter (2001) and modiﬁed by
Taiwo et al. (2013). The bacteria strains used were from 24 h
nutrient agar plate cultures and the colonies were suspended
in sterile distilled water in order to obtain bacteria load of
approximately 106 CFU/mL, by comparison with the
McFarland tube No. 0.5. These were then used in the micro-
wells. The compounds were tested at concentrations ranging
from 2 to 0.0078125 mg/mL. Streptomycin (Shijiazhuang, China)
was used at the concentration range of 1000–3.90625 lg/mL
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plates were sealed and thereafter incubated overnight at
37 C.
Microbial growth was determined by careful observation
for growth in bright light and conﬁrmed by determining the
absorbance at 630 nm using the DNM-9602 universal micro-
plate reader as described by Aderogba et al. (2011) following
the protocol of Jorgensen and Turnidge (2007). The MIC
was deﬁned as the lowest concentration of each of the com-
pounds that inhibits the growth of bacteria. MBC was deter-
mined by plating drops from concentrations that showed
inhibition of growth on freshly prepared Nutrient Agar plates.
After 24-hr incubation at 37 C the lowest concentration at
which growth could not be recovered was taken as the MBC.
2.6.4. Statistical analysis
Concentration–response curves were plotted using both linear
regression plot and non-linear plot as appropriate on a Prism
Software package 5.00 for windows (Graphpad San Diego
California, USA). Sample’s data were obtained from three
independent experiments with each performed in triplicate
(n= 9) and represented as mean ± SD.
3. Results and discussion
3.1. Structure elucidation
A bioactivity directed fractionation was used to target the anti-
oxidative constituents in the EtOAc fraction of the 80%
MeOH extract of leaves of A. occidentale. Repeated column
chromatography and further puriﬁcation by Sephadex LH-20
yielded a bioﬂavonoid, agathisﬂavone (1), and a mixture of
quercetin 3-O-rutinoside (2) and quercetin 3-O-rhamnoside
(3), (ratio 2:1). The isolated compounds were characterized
using spectroscopic techniques: NMR (1D and 2D) and mass
spectrometry (ESI-TOF-MS).
3.2. Antioxidant activities
Quantitative antioxidant activities of the crude extract, solvent
fractions and isolated compounds were determined using three
complementary antioxidant assays DPPH-radical scavenging,
Total Antioxidant Capacity (TAC) and Ferric Reducing Anti-
oxidant Power (FRAP) assays. The results of assays are shown
in Tables 1–3. Of all the extracts, ethyl acetate fraction was the
most active in the DPPH assay (IC50 = 5.66 ± 0.16 lg/mL)
and the mixture of quercetin 3-O-rutinoside (2) and quercetin
3-O-rhamnoside (3), (ratio 2:1) elicited the highest activity
(IC50 = 0.966 ± 0.01 lg/mL) amongst the test samples includ-
ing the two standards (ascorbic acid and quercetin) used in the
assay, (Table 1). Similarly, in the TAC and FRAP assays the
mixture of compounds (2) and (3) ratio (2:1), exhibited a
higher activity than the other test samples with values of
5332.00 ± 3.38 mg AAE/g, and 8562.00 ± 5.43 mg QE/g in
the TAC assay and (15136.00 ± 7.14 mg AAE/g, and
199530.00 ± 94.12 mg QE/g) in the FRAP assay respec-
tively(Tables 2 and 3).
The antioxidant activity reported in this study for the iso-
lated compounds in the DPPH assay is in agreement with sim-
ilar studies undertaken on the compounds. For instance
Bansala et al. (2011) reported quercetin 3-O-rutinoside fromPilea microphylla with an IC50 value 20.40 ± 0.3 lmol/L. In
another study, Bonacorsi et al. (2011) reported quercetin 3-
O-beta-D-galactopyranoside from Anacardium humile with an
EC50 value 9.9 lg/mL. Recently, Li et al. (2014) reported
amentoﬂavone with IC50 value 232.55 ± 45.22 lg/mL. In this
study however, the difference in activity recorded for agathisf-
lavone in the DPPH assay (IC50 value 336.37 ± 32.59 lg/mL)
compared to amentoﬂavone could be ascribed to differences in
substitution pattern of the two biﬂavonoids. In considering the
activity given by the mixture of compounds 2 and 3 in the
DPPH assay the potent activity (IC50 value 0.96 ± 0.01 lg/
mL) observed can be adduced to the additive combination of
the two compounds.3.3. Antimicrobial activities
The compounds were screened for possible antibacterial and
antifungal activities using two fungi strains as well as three
Gram-positive and four Gram-negative bacteria. The Gram-
positive bacteria were B. subtilis, NCIB 3610; S. aureus ATCC
29213, and Cl. sporogens NCIB 532. The Gram-negative bac-
teria were E. coli ATCC 25922, P. aeruginosa ATCC 27853,
P. mirabilis (clinical strain) and K. pneumonia (clinical strain),
while C. albicans NCYC 6 and C. pseudotropicalis (clinical
strain) were the fungi. The standard antimicrobial agents used
were acriﬂavine and streptomycin.
The plant investigated is used in ethnomedicine to treat a
wide variety of conditions including infectious diseases. The
crude extract of A. occidentale has little activity against the
selected bacteria and no activity against the fungi at the concen-
trations tested. The fractions of the extract showed compara-
tively better activities against gram-negative bacteria than the
gram positive ones with the broadest spectrum of activities
demonstrated for the ethyl acetate fraction (Table 4). No inhi-
bitions were obtained against the fungal strains investigated.
The isolated compounds from the plant were further
screened against these bacteria strains to determine their con-
tribution to the antimicrobial activities. The results obtained
indicated that the identiﬁed compounds possess essentially
inhibitory rather than cidal activities against these organisms.
The mixture of compounds 2 and 3 (ratio 2:1), showed higher
activity than compound 1 with the former having MIC as low
as 0.25 mg/mL against P. aeruginosa and Cl. sporogens,
0.5 mg/mL against S. aureus and 1.0 mg/mL against E. coli,
K. pneumonia and P. sporogens. The MIC of compound 1
was observed to be 1.0 mg/mL against most of the bacteria
tested except Cl. sporogens where an MIC of 0.5 mg/mL was
obtained. The MBC of the compounds was also greater than
2.0 mg/mL in all cases (Table 5).
Compound 1 is agathisﬂavone which is a biﬂavonoid. A
number of biological activities have been reported for this
group of ﬂavonoid, for instance Cushnie and Lamb (2005)
and Pegnyemb et al. (2005) reported antibacterial activity,
while Njock et al. (2012) reported anti-inﬂammatory activity.
For agathisﬂavone (1), activities previously reported are anti-
neoplastic, hepatoprotective and antiviral properties (Konan
et al., 2012; Njock et al., 2012). In this study, it is demonstrated
that this compound also possesses inhibitory antibacterial
activities against a wide spectrum of organisms.
Quercetin and its glycosides have also been reported to dem-
onstrate antiviral, antibacterial, anti-inﬂammatory, anticancer
Table 4 In-vitro antimicrobial activity of the crude extract and fractions of Anacardium occidentale.*
Agent Organisms Concentration (mg/mL) Diameter of zone of inhibition (mm)**
Crude extract Escherichia coli ATCC 25922 10.0 4.0
20.0 7.0
Bacillus subtilis NCIB 3610 10.0 5.0
20.0 7.0
Butanol fraction Escherichia coli ATCC 25922 5.0 3.0
10.0 4.0
20.0 6.0
Pseudomonas aeruginosa ATCC 27853 20.0 3.0
Bacillus subtilis NCIB 3610 10.0 1.0
20.0 5.0
DCM fraction Escherichia coli ATCC 25922 0.5–10.0 8.0
20.0 13.0
Pseudomonas aeruginosa ATCC 27853 10.0–20.0 3.0
Ethyl acetate fraction Escherichia coli ATCC 25922 1.0–2.0 4.0
5.0–10.0 5.0
20.0 9.0
Pseudomonas aeruginosa ATCC 27853 1.0–2.0 4.0
5.0 6.0
10.0 7.0
20.0 8.0
S. aureus ATCC 29213 2.0 5.0
5.0–20.0 7.0
Proteus mirabilis (clinical) 2.0–5.0 4.0
10.0 6.0
20.0 8.0
Bacillus subtilis NCIB 3610 1.0–5.0 2.0
10.0 5.0
20.0 10.0
K. pneumonia (clinical) 5.0 5.0
10.0 10.0
20.0 15.0
Cl. sporogens NCIB 532 2.0 4.0
5.0–10.0 6.0
20.0 8.0
Hexane fraction Escherichia coli ATCC 25922 0.5–20.0 8.0
S. aureus ATCC 29213 20.0 5.0
Bacillus subtilis NCIB 3610 20.0 4.0
Cl. sporogens NCIB 532 20.0 4.0
Diameter of zone of inhibition of streptomycin (1 mg/mL) for each organism was: E. coli ATCC 25922, 14.0 mm; P. aeruginosa ATCC 27853,
14.0 mm; S. aureus ATCC 29213, 14.0 mm; P. mirabilis (clinical), 13.0 mm; B. subtilis NCIB 3610, 14.0 mm; K. pneumonia (clinical), 13.0 mm;
Cl. sporogens NCIB 532, 10.0 mm.
* The agents showed activities only against the organisms indicated.
** Zone of inhibition less cup size.
Table 5 Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC) in mg/mL of the compounds.
Organisms Streptomycin Compound 1 Compound 2 and 3
MIC MBC MIC MBC MIC MBC
B. subtilis NCIB 3610 0.50 0.500 1.00 >2.00 0.500 >2.00
Cl. sporogens NCIB 532 0.125 0.500 0.500 >2.00 0.250 >2.00
E. coli ATCC 25922 0.125 0.500 1.00 >2.00 1.00 >2.00
K. pneumonia (clinical) 0.125 0.500 1.00 >2.00 1.00 >2.00
P. ﬂuorescence NCIB 3756 0.50 0.500 1.00 >2.00 1.00 >2.00
P. aeruginosa ATCC 27853 0.50 0.500 1.00 >2.00 0.250 >2.00
S. aureus ATCC 29213 0.125 0.500 1.00 >2.00 0.500 >2.00
250 O.O. Ajileye et al.and other biological activities (Yu et al., 2007; Davis et al.,
2009). A mixture of quercetin 3-O-rutinoside (2) and quercetin
3-O-rhamnoside (3) isolated in this study are glycosides ofquercetin with rutinosyl and rhamnosyl respectively. Quercetin
3-O-rutinoside (2) has been reported to contribute to the
antibacterial and antioxidant properties of some plant species
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therefore be inferred that the antibacterial activities reported
for the mixture of compounds 2 and compound 3 are mainly
due to the synergistic effects since the two compounds have
the same ﬂavonoid nucleus.
The good activities demonstrated by the mixture of 2 and 3
against P. aeruginosa, a pathogen characterized by a low
intrinsic susceptibility to most antimicrobial agents and Cl.
sporogens, a sporulating organism, also with intrinsically high
resistance properties is highly instructive. It is an indication
that this mixture could be utilized as effective agents against
pseudomonal and clostridial infections that are often reported
and known to be highly recalcitrant to therapy. The speciﬁcity
in activities may be employed maximally in targeted therapy.
The ethyl acetate fraction of the plant extract and identiﬁed
chemical isolates may therefore be a readily available source
of cheap and potent antimicrobial agents to be used in the
therapy of infections caused by these often multi resistant
organisms.
It has been shown also that the degree of antimicrobial
activities of ﬂavonoids depends largely on the freedom of the
attached phenolic groups (Alcaraz et al., 2000). Those with
free phenolic groups have been reported to demonstrate better
antimicrobial activity than their substituted counterparts
(Alcaraz et al., 2000; Aderogba et al., 2011). This observation
is also demonstrated by the results of this study as slightly
higher antibacterial activities are demonstrated for mixture
of 2 and 3 compared with compound 1. Further to these, the
lack of inhibitory effects by the extracts and fractions of this
plant against the fungal strains is not out of place because
these compounds have not been reported to express signiﬁcant
antifungal activities.
This study has established that the extracts and isolated
compounds have strong antioxidant and moderate antimicro-
bial activities and could be effective in the management of oxi-
dative stress and infectious related diseases. The ﬁndings
justiﬁed the use of this plant in folk medicine.
In conclusion, the use of A. occidentale L. in the manage-
ment of oxidative stress and infectious related diseases
prompted us to investigate the antioxidant and antimicrobial
constituents of this plant extracts. Based on the qualitative
antioxidant screening using DPPH TLC assay, all the four sol-
vent fractions (hexane, dichloromethane, ethyl acetate and
butanol) contained antioxidant compounds. However, ethyl
acetate fraction contained the highest number of antioxidant
compounds and showed the broadest antibacterial spectrum
of activities. A DPPH directed fractionation of the ethyl ace-
tate fraction afforded agathisﬂavone (1) and a mixture of quer-
cetin 3-O-rutinoside (2) and quercetin 3-O-rhamnoside (3). The
plant extracts and identiﬁed constituents demonstrated varying
degree of activities in the three antioxidant assays. The
compounds also exhibited a broad spectrum of antimicrobial
activities. These ﬁndings provided a rationale for the ethnome-
dicinal use of the plant in traditional medicine.
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